合成路线1
该中间体在本合成路线中的序号:
(XXIII) Tyrosine methyl ester (XXIII) was acylated with butanesulfonyl chloride (XIV) in the presence of pyridine to produce sulfonamide (XXIV). Mitsunobu coupling of pyridinyl butanol (XX) with the phenolic compound (XXIV) furnished ether (XXV). Subsequent hydrolysis of the methyl ester group of (XXV) employing LiOH afforded acid (XXVI). The title piperidine compound was then obtained by catalytic hydrogenation of the pyridine ring of (XXVI) in the presence of Pd/C.
【1】
Chung, J.Y.L.; Zhao, D.; Hughes, D.L. (Merck & Co., Inc.); Process for preparing fibrinogen receptor antagonists. US 5312923; WO 9316994 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIV) |
26779 |
1-butanesulfonyl chloride
|
2386-60-9 |
C4H9ClO2S |
详情 | 详情
|
(XX) |
59550 |
4-(4-pyridinyl)-1-butanol
|
|
C9H13NO |
详情 |
详情
|
(XXIII) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(XXIV) |
59552 |
methyl (2S)-2-[(butylsulfonyl)amino]-3-(4-hydroxyphenyl)propanoate
|
|
C14H21NO5S |
详情 |
详情
|
(XXV) |
59553 |
methyl (2S)-2-[(butylsulfonyl)amino]-3-{4-[4-(4-pyridinyl)butoxy]phenyl}propanoate
|
|
C23H32N2O5S |
详情 |
详情
|
(XXVI) |
59554 |
(2S)-2-[(butylsulfonyl)amino]-3-{4-[4-(4-pyridinyl)butoxy]phenyl}propanoic acid
|
|
C22H30N2O5S |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The reaction of L-tyrosine methyl ester (I) with ethyl chloroformate and K2CO3 in water gives the carbamate (II), which is protected with Bn-Br and K2CO3 in DMF, yielding the benzyl ether (III). The reduction of (III) by means of LiAlH4 in refluxing THF affords the chiral 2-methylaminopropanol (IV), which is protected as its Boc derivative (V) by means of Boc2O. The oxidation of (V) by means of DMP provides the carbaldehyde (VI), which is reductocondensed with glycine methyl ester (VII) by means of NaBH3CN in methanol to give the adduct (VIII). Elimination of the Boc protecting group of (VIII) by means of TFA yields the diamine (IX), which is cyclized by means of NH4OH in ethanol to afford the piperazinone (X). Elimination of the benzyl protecting group of (X) by hydrogenation with H2 over Pd/C provides the phenol (XIa)-(XIb), which is cyclized by means of bis(acetoxy)iodobenzene in hexafluoroisopropanol to give the spiranic cyclohexadienone (XII). The hydrogenation of (XII) by means of Tes-H and CuI in dichloromethane yields the spiranic cyclohexanone (XIII), which is finally ketalized by means of ethyleneglycol (XIV) and PPTS in refluxing benzene to provide the target ethyleneketal intermediate (XV) (See scheme no. 18599903a, intermediate (XV)).
【1】
Mizutani, H.; et al.; Facile synthesis of enantiopure (-)-TAN1251A. Tetrahedron Lett 2002, 43, 13, 2411.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(II) |
57099 |
methyl (2S)-2-[(ethoxycarbonyl)amino]-3-(4-hydroxyphenyl)propanoate
|
|
C13H17NO5 |
详情 |
详情
|
(III) |
57100 |
methyl (2S)-3-[4-(benzyloxy)phenyl]-2-[(ethoxycarbonyl)amino]propanoate
|
|
C20H23NO5 |
详情 |
详情
|
(IV) |
57101 |
(2S)-3-[4-(benzyloxy)phenyl]-2-(methylamino)-1-propanol
|
|
C17H21NO2 |
详情 |
详情
|
(V) |
57102 |
tert-butyl (1S)-1-[4-(benzyloxy)benzyl]-2-hydroxyethyl(methyl)carbamate
|
|
C22H29NO4 |
详情 |
详情
|
(VI) |
57103 |
tert-butyl (1S)-1-[4-(benzyloxy)benzyl]-2-oxoethyl(methyl)carbamate
|
|
C22H27NO4 |
详情 |
详情
|
(VII) |
17568 |
methyl 2-aminoacetate
|
|
C3H7NO2 |
详情 |
详情
|
(VIII) |
57104 |
methyl 2-({(2S)-3-[4-(benzyloxy)phenyl]-2-[(tert-butoxycarbonyl)(methyl)amino]propyl}amino)acetate
|
|
C25H34N2O5 |
详情 |
详情
|
(IX) |
57105 |
methyl 2-{[(2S)-3-[4-(benzyloxy)phenyl]-2-(methylamino)propyl]amino}acetate
|
|
C20H26N2O3 |
详情 |
详情
|
(X) |
57106 |
(6S)-6-[4-(benzyloxy)benzyl]-1-methyl-2-piperazinone
|
|
C19H22N2O2 |
详情 |
详情
|
(XI) |
57107 |
(6S)-6-(4-hydroxybenzyl)-1-methyl-2-piperazinone
|
|
C12H16N2O2 |
详情 |
详情
|
(XII) |
57108 |
|
|
C12H14N2O2 |
详情 |
详情
|
(XIII) |
57109 |
|
|
C12H18N2O2 |
详情 |
详情
|
(XIV) |
11295 |
Polyethylene glycol;1,2-Ethanediol;Monoethylene glycol; Ethylene glycol |
107-21-1 |
C2H6O2 |
详情 | 详情
|
(XV) |
48806 |
|
|
C14H22N2O3 |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) Racemic cyclohexylphenyl glycolic acid (CHPGA) (I) is dissolved with (L)-tyrosine methyl ester (II) in refluxing acetonitrile/water to yield a mixture of diastereomeric salts, which is resolved by crystallization to afford the desired diastereomeric salt [(S)-CHPGA-(L)-TME] (III). Finally, the hydrolysis of salt (III) with HCl or H2SO4 at 40-50ºC in toluene yields the enantiomer (IV).
Alternatively intermediate (IV) can be obtained as follows: acetalization of (S)-mandelic acid (V) with pivaldehyde (VI) in pentane and catalytic TfOH provides derivative (VII), which is then treated with LHMDS and then condensed with cyclohexanone (VIII) in THF to furnish aldol adduct (IX). Elimination of tertiary alcohol in (IX) with SOCl2 and pyridine in THF gives derivative (X), which is then converted into intermediate (IV) either by first hydrolysis of lactone (X) with KOH in MeOH and subsequent hydrogenation of the obtained derivative (XI) over Pd/C in MeOH, or by first hydrogenation of (X) over Pd/C in MeOH to give (XII), followed by hydrolysis with KOH in MeOH. On turn, derivative (XII) can alternatively be synthesized by treatment of derivative (VII) with LHMDS, followed by reaction with 3-bromocyclohexene (XIII) in THF to provide derivative (XIV), which is then hydrogenated over Pd/C.
【1】
Grover, P.T.; et al.; Chiral mandelic acid template provides a highly practical solution for (S)-oxybutynin synthesis. J Org Chem 2000, 65, 19, 6283.
|
【2】
Senanayake, C.H.; Bakale, R.P.; Vandenbossche, C.P.; McConville, F.X.; Lopez, J.L. (Sepracor Inc.); Synthesis of optically active cyclohexylphenylglycolic acid and its esters. US 5973182; US 6140529; WO 0023414 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(Ia) |
51214 |
(2R)-2-cyclohexyl-2-hydroxy-2-phenylethanoic acid
|
|
C14H18O3 |
详情 |
详情
|
(Ib),(IV) |
51215 |
(2S)-2-cyclohexyl-2-hydroxy-2-phenylethanoic acid
|
|
C14H18O3 |
详情 |
详情
|
(II) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(III) |
51216 |
|
n/a |
C24H31NO6 |
详情 | 详情
|
(V) |
12563 |
(2S)-2-Hydroxy-2-phenylethanoic acid; S-(+)-Mandelic acid
|
17199-29-0 |
C8H8O3 |
详情 | 详情
|
(VI) |
19797 |
Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal
|
630-19-3 |
C5H10O |
详情 | 详情
|
(VII) |
31681 |
(2R,5R)-2-(tert-butyl)-5-phenyl-1,3-dioxolan-4-one
|
|
C13H16O3 |
详情 |
详情
|
(VIII) |
11059 |
Cyclohexanone
|
108-94-1 |
C6H10O |
详情 | 详情
|
(IX) |
51217 |
(2S,5R)-2-(tert-butyl)-5-(1-hydroxycyclohexyl)-5-phenyl-1,3-dioxolan-4-one
|
|
C19H26O4 |
详情 |
详情
|
(X) |
51218 |
(2S,5S)-2-(tert-butyl)-5-(1-cyclohexen-1-yl)-5-phenyl-1,3-dioxolan-4-one
|
|
C19H24O3 |
详情 |
详情
|
(XI) |
51219 |
(2S)-2-(1-cyclohexen-1-yl)-2-hydroxy-2-phenylethanoic acid
|
|
C14H16O3 |
详情 |
详情
|
(XII) |
51220 |
(2S,5S)-2-(tert-butyl)-5-cyclohexyl-5-phenyl-1,3-dioxolan-4-one
|
|
C19H26O3 |
详情 |
详情
|
(XIII) |
30800 |
3-bromo-1-cyclohexene
|
1521-51-3 |
C6H9Br |
详情 | 详情
|
(XIV) |
51221 |
(2S,5S)-2-(tert-butyl)-5-[(1R)-2-cyclohexen-1-yl]-5-phenyl-1,3-dioxolan-4-one
|
|
C19H24O3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) Condensation of L-tyrosine methyl ester (I) with 2-benzoylcyclohexanone (II) in the presence of Pd/C in boiling anisole produced the vinylogous amide intermediate (III) which, in the reaction conditions, experienced a dehydrogenation to furnish benzophenone (IV). Then, coupling of (IV) with 2-(5-methyl-2-phenyloxazol-4-yl)ethanol (V) under Mitsunobu conditions afforded ether (VI). Finally, the ester function of (VI) was hydrolyzed with LiOH to give the title acid.
【1】
Martín, L.; Sorbera, L.A.; Leeson, P.A.; Castañer, J.; Farglitazar. Drugs Fut 2001, 26, 4, 354.
|
【2】
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
|
【3】
Willson, T.M.; Mook, R.A. Jr.; Kaldor, I.; Henke, B.R.; Deaton, D.N.; Collins, J.L.; Cobb, J.E.; Brackeen, M.; Sharp, M.J.; O'Callaghan, J.M.; Erickson, G.A.; Boswell, G.E. (Glaxo Wellcome plc); Substd. 4-hydroxy-phenylalkanoic acid derivs. with agonist activity to PPAR-gamma. EP 0888317; JP 2000507216; WO 9731907 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(II) |
21432 |
2-benzoylcyclohexanone
|
3580-38-9 |
C13H14O2 |
详情 | 详情
|
(III) |
21433 |
methyl (2S)-2-[(2-benzoyl-1-cyclohexen-1-yl)amino]-3-(4-hydroxyphenyl)propanoate
|
|
C23H25NO4 |
详情 |
详情
|
(IV) |
21434 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate
|
|
C23H21NO4 |
详情 |
详情
|
(V) |
19874 |
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol
|
|
C12H13NO2 |
详情 |
详情
|
(VI) |
21436 |
methyl (2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoate
|
|
C35H32N2O5 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) Coupling of N-acetyl-D-thioproline (I) with tyrosine methyl ester (II) using EDC and HOBt yielded dipeptide (III). Subsequent alkylation of the tyrosine phenolic group of (III) with 2,6-dichlorobenzyl bromide (IV) and NaH produced the dichlorobenzyl ether (V). The methyl ester group of (V) was finally hydrolyzed employing LiOH in aqueous THF.
【1】
Head, J.C.; Warrellow, G.J.; Archibald, S.C. (Celltech Chiroscience plc); Anti-inflammatory tyrosine derivs.. EP 0984981; US 6093696; WO 9854207 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40791 |
(4S)-3-acetyl-1,3-thiazolidine-4-carboxylic acid
|
24877-72-3 |
C6H9NO3S |
详情 | 详情
|
(II) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(III) |
40792 |
methyl (2S)-2-([[(4S)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl]amino)-3-(4-hydroxyphenyl)propanoate
|
|
C16H20N2O5S |
详情 |
详情
|
(IV) |
40793 |
2-(bromomethyl)-1,3-dichlorobenzene
|
20443-98-5 |
C7H5BrCl2 |
详情 | 详情
|
(V) |
40794 |
methyl (2S)-2-([[(4S)-3-acetyl-1,3-thiazolidin-4-yl]carbonyl]amino)-3-[4-[(2,6-dichlorobenzyl)oxy]phenyl]propanoate
|
|
C23H24Cl2N2O5S |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The borinated tyrosine intermediate (VII) has been obtained as follows: The esterification of L-tyrosine (I) with SOCl2 and methanol gives the methyl ester (II), which is N-protected with Cbz-Cl and K2CO3 to yield the carbamate (III). The O-protection of (III) with benzyl bromide and Cs2CO3 affords the benzyl ether (IV), which is iodinated with I2 and Ag2SO4 to provide the 3-iodotyrosine derivative (V). Finally, the borylation of (V) by means of pinacolatodiborane (VI) catalyzed by PdCl2[bis(diphenylphosphanyl)ferrocene] (PdCl2(dppf)) gives rise to the target tyrosine intermediate (VII).
【1】
Lin, S.N.; Danishefsky, S.J.; The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: Discovery of a new method to generate cis-propenyl amides. Angew Chem. Int Ed 2002, 41, 3, 512.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48794 |
(S)-(-)-Tyrosine; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; L-(-)-Tyrosine; L-3-(4-Hydroxyphenyl)alanine; L-4-Hydroxy-17O-phenylalanine; L-beta-(p-Hydroxyphenyl)alanine; L-Hydroxy Phenyl Alanine; L-tyrosine
|
60-18-4 |
C9H11NO3 |
详情 | 详情
|
(II) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(III) |
53339 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoate
|
n/a |
C18H19NO5 |
详情 | 详情
|
(IV) |
53340 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)phenyl]propanoate
|
n/a |
C25H25NO5 |
详情 | 详情
|
(V) |
53341 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-iodophenyl]propanoate
|
n/a |
C25H24INO5 |
详情 | 详情
|
(VI) |
53342 |
4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane; Bis(pinacolato)diboron; Diboron pinacol ester
|
73183-34-3 |
C12H24B2O4 |
详情 | 详情
|
(VII) |
53343 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate
|
n/a |
C31H36BNO7 |
详情 | 详情
|
合成路线7
该中间体在本合成路线中的序号:
(I) The 2-aminobenzophenone derivative (III) was prepared by condensation of L-tyrosine methyl ester (I) with 2-benzoylcyclohexanone (II) in refluxing anisole, with concomitant dehydrogenation in the presence of Pd/C. Subsequent Mitsunobu coupling of (III) with 2-(N-Boc-N-methylamino)ethanol (V), prepared from aminoalcohol (IV) and Boc2O, afforded the Boc-protected aminoethyl ether (VI). After removal of the Boc group of (VI) by treatment with trifluoroacetic acid, condensation of the resulting secondary amine (VII) with 2-fluoropyridine (VIII) yielded the 2-aminopyridine derivative (IX). Finally, the methyl ester group of (IX) was hydrolyzed to the title carboxylic acid using LiOH.
【1】
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
|
【2】
Willson, T.M.; Mook, R.A. Jr.; Kaldor, I.; Henke, B.R.; Deaton, D.N.; Collins, J.L.; Cobb, J.E.; Brackeen, M.; Sharp, M.J.; O'Callaghan, J.M.; Erickson, G.A.; Boswell, G.E. (Glaxo Wellcome plc); Substd. 4-hydroxy-phenylalkanoic acid derivs. with agonist activity to PPAR-gamma. EP 0888317; JP 2000507216; WO 9731907 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
23767 |
Methoxybenzene; Methyl phenyl ether; Anisole
|
100-66-3 |
C7H8O |
详情 | 详情
|
(I) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(II) |
21432 |
2-benzoylcyclohexanone
|
3580-38-9 |
C13H14O2 |
详情 | 详情
|
(III) |
21434 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate
|
|
C23H21NO4 |
详情 |
详情
|
(IV) |
13324 |
2-Methylaminoethanol; 2-(Methylamino)-1-ethanol
|
109-83-1 |
C3H9NO |
详情 | 详情
|
(V) |
34509 |
tert-butyl 2-hydroxyethyl(methyl)carbamate
|
|
C8H17NO3 |
详情 |
详情
|
(VI) |
34510 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-[2-[(tert-butoxycarbonyl)(methyl)amino]ethoxy]phenyl)propanoate
|
|
C31H36N2O6 |
详情 |
详情
|
(VII) |
34511 |
methyl (2S)-2-(2-benzoylanilino)-3-[4-[2-(methylamino)ethoxy]phenyl]propanoate
|
|
C26H28N2O4 |
详情 |
详情
|
(VIII) |
34512 |
2-fluoropyridine
|
372-48-5 |
C5H4FN |
详情 | 详情
|
(IX) |
34513 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-[2-[methyl(2-pyridinyl)amino]ethoxy]phenyl)propanoate
|
|
C31H31N3O4 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(II) The borinated tyrosine intermediate (VII) has been obtained as follows: The esterification of L-tyrosine (I) with SOCl2 and methanol gives the methyl ester (II), which is N-protected with Cbz-Cl and K2CO3 to yield the carbamate (III). The O-protection of (III) with benzyl bromide and Cs2CO3 affords the benzyl ether (IV), which is iodinated with I2 and Ag2SO4 to provide the 3-iodotyrosine derivative (V). Finally, the borylation of (V) by means of pinacolatodiborane (VI) catalyzed by PdCl2[bis(diphenylphosphanyl)ferrocene] (PdCl2(dppf)) gives rise to the target tyrosine intermediate (VII).
【1】
Lin, S.N.; Danishefsky, S.J.; The total synthesis of proteasome inhibitors TMC-95A and TMC-95B: Discovery of a new method to generate cis-propenyl amides. Angew Chem. Int Ed 2002, 41, 3, 512.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
48794 |
(S)-(-)-Tyrosine; (S)-2-Amino-3-(4-hydroxyphenyl)propionic acid; 3-(4-Hydroxyphenyl)-L-alanine; L-(-)-Tyrosine; L-3-(4-Hydroxyphenyl)alanine; L-4-Hydroxy-17O-phenylalanine; L-beta-(p-Hydroxyphenyl)alanine; L-Hydroxy Phenyl Alanine; L-tyrosine
|
60-18-4 |
C9H11NO3 |
详情 | 详情
|
(II) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(III) |
53339 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-(4-hydroxyphenyl)propanoate
|
n/a |
C18H19NO5 |
详情 | 详情
|
(IV) |
53340 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)phenyl]propanoate
|
n/a |
C25H25NO5 |
详情 | 详情
|
(V) |
53341 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-iodophenyl]propanoate
|
n/a |
C25H24INO5 |
详情 | 详情
|
(VI) |
53342 |
4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi-1,3,2-dioxaborolane; Bis(pinacolato)diboron; Diboron pinacol ester
|
73183-34-3 |
C12H24B2O4 |
详情 | 详情
|
(VII) |
53343 |
methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[4-(benzyloxy)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate
|
n/a |
C31H36BNO7 |
详情 | 详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) Condensation of L-tyrosine methyl ester (I) with 2-benzoylcylohexanone (II) and subsequent dehydrogenation in refluxing anisole in the presence of Pd/C affords the benzophenone derivative (III), which is converted into carboxylic acid (V) by Mitsunobu reaction with heterocyclic alcohol (IV) by means of PPh3 and DEAD in THF followed by saponification of the resulting methyl ester with LiOH in THF/MeOH (1). Coupling of (V) with valinol (VI) by means of HOBt/Et3N and EDC·HCl in CH2Cl2 furnishes amide (VII), which is oxidized by means of 4-methylmorpholine (NMM) and TPAP in CH2Cl2 to furnish aldehyde (VIII). Finally, the desired oxazole is obtained by intramolecular cyclization of (VIII) by means of iodine, PPh3 and Et3N in CH2Cl2.
【1】
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
|
【2】
Cobb, J.E.; Shearer, B.G.; Lambert, M.H. III; Milburn, M.V. (Glaxo Group Ltd.); Oxazole PPAR antagonists. WO 0117994 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(II) |
21432 |
2-benzoylcyclohexanone
|
3580-38-9 |
C13H14O2 |
详情 | 详情
|
(III) |
21434 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate
|
|
C23H21NO4 |
详情 |
详情
|
(IV) |
19874 |
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol
|
|
C12H13NO2 |
详情 |
详情
|
(V) |
48285 |
(2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propionic acid
|
|
C34H30N2O5 |
详情 |
详情
|
(VI) |
48289 |
2-amino-3-methyl-1-butanol; DL-Valinol
|
473-75-6 |
C5H13NO |
详情 | 详情
|
(VII) |
48287 |
(2S)-2-(2-benzoylanilino)-N-[1-(hydroxymethyl)-2-methylpropyl]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanamide
|
|
C39H41N3O5 |
详情 |
详情
|
(VIII) |
48288 |
(2S)-2-(2-benzoylanilino)-N-(1-formyl-2-methylpropyl)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanamide
|
|
C39H39N3O5 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(I) Condensation of L-tyrosine methyl ester (I) with 2-benzoylcylohexanone (II) and subsequent dehydrogenation in refluxing anisole in the presence of Pd/C affords the benzophenone derivative (III), which is converted into carboxylic acid (V) by Mitsunobu reaction with heterocyclic alcohol (IV) by means of PPh3 and DEAD in THF followed by saponification of the resulting methyl ester with LiOH in THF/MeOH (1). Coupling of (V) with acetic acid hydrazide (VI) by means of HOBt/Et3N and EDC.HCl in CH2Cl2 furnishes the diacyl hydrazide (VII), which is finally converted into the desired thiadiazole derivative by treatment with Lawesson's Reagent in refluxing toluene.
【1】
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel serieis of potent antihyperglycemic and antihyperlipidemic agents. J Med Chem 1998, 41, 25, 5020.
|
【2】
Cobb, J.E.; Shearer, B.G.; Lambert, M.H. III; Milburn, M.V. (Glaxo Group Ltd.); Oxazole PPAR antagonists. WO 0117994 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21431 |
methyl (2S)-2-amino-3-(4-hydroxyphenyl)propanoate
|
1080-06-4 |
C10H13NO3 |
详情 | 详情
|
(II) |
21432 |
2-benzoylcyclohexanone
|
3580-38-9 |
C13H14O2 |
详情 | 详情
|
(III) |
21434 |
methyl (2S)-2-(2-benzoylanilino)-3-(4-hydroxyphenyl)propanoate
|
|
C23H21NO4 |
详情 |
详情
|
(IV) |
19874 |
2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)-1-ethanol
|
|
C12H13NO2 |
详情 |
详情
|
(V) |
48285 |
(2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propionic acid
|
|
C34H30N2O5 |
详情 |
详情
|
(VI) |
29262 |
acetohydrazide
|
1068-57-1 |
C2H6N2O |
详情 | 详情
|
(VII) |
48286 |
(2S)-N'-acetyl-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanohydrazide
|
|
C36H34N4O5 |
详情 |
详情
|